Molecular Mechanisms of Podocyte Development Revealed by Zebrafish Kidney Research

Por Miceli, R, Kroeger, PT, Wingert, RA
Publicado no Cell Dev Biol (2014)

Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group.

Por Bozzetti, F, Marubini, E, Bonfanti, G, Miceli, R, Piano, C, Crose, N, Gennari, L
Publicado em 1997

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial

Por Procopio, G, Verzoni, E, Bracarda, S, Ricci, S, Sacco, C, Ridolfi, L, Porta, C, Miceli, R, Zilembo, N, Bajetta, E
Publicado em 2011

O10.10 RESULTS OF NIMOTUZUMAB AND VINORELBINE, RADIATION AND RE-IRRADIATION FOR DIFFUSE PONTINE GLIOMA IN CHILDHOOD

Por Massimino, M., Biassoni, V., Miceli, R., Schiavello, E., Warmuth-Metz, M., Modena, P., Giangaspero, F., Spreafico, F., Bach, F., Gandola, L.
Publicado em 2014

Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors

Por Wakelee, H. A., Patnaik, A., Sikic, B. I., Mita, M., Fox, N. L., Miceli, R., Ullrich, S. J., Fisher, G. A., Tolcher, A. W.
Publicado em 2010

Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis

Por Bossi, P., Orlandi, E., Miceli, R., Perrone, F., Guzzo, M., Mariani, L., Granata, R., Locati, L., Fallai, C., Cortelazzi, B., Pilotti, S., Scaramellini, G., Gloghini, A., Licitra, L.
Publicado no Ann Oncol (2014)

A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma

Por Younes, A, Vose, J M, Zelenetz, A D, Smith, M R, Burris, H A, Ansell, S M, Klein, J, Halpern, W, Miceli, R, Kumm, E, Fox, N L, Czuczman, M S
Publicado em 2010